Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Phase 4TerminatedNCT00804206

Asociación para Evitar la Ceguera en México15 enrolled

Overview

Compare the effect of an intravitreal injection of bevacizumab previous or posterior of panretinal laser photocoagulation (PRLP) with a pattern laser; to prevent and reduce diabetic macular edema (DME) in patients with proliferative diabetic retinopathy (PDR) with DME.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Macular Edema

Interventions

bevacizumabDRUG

Intravitreal bevacizumab before panretinal photocoagulation

bevacizumabDRUG

Intravitreal Bevacizumab after panretinal photocoagulation

Eligibility

Sex: ALLMin age: 40 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with proliferative diabetic retinopathy * patients with macular edema Exclusion Criteria: * patients with previous treatments * patients with ocular surgeries

Locations (1)

Asociación para Evitar la Ceguera en México

México, Mexico

Outcomes

Primary Outcomes

Central macular thickness

Time frame: baseline, 10 days, 52 days, 85 days

Secondary Outcomes

Best corrected visual acuity

Time frame: baseline, 10 days, 52 days, 85 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.